pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 1·1 min read
save

Anthropic’s Claude Science signals AI firms are taking health research seriously

Jul 1, 2026·read at STAT ↗Positive

Brittany Trang, a health‑tech reporter, notes that Anthropic’s new Claude Science model shows major AI developers are turning toward genuine scientific work rather than only high‑profile demos.

The AI Prognosis newsletter highlights the release as a sign that large language models are being applied to real health and medicine challenges, suggesting a shift in the industry’s focus.

Trang also shares a personal note about the puzzle game Multiplet, which she and a friend enjoy, and reminds readers of the newsletter’s publishing schedule.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The moment Anthropic convinced me it’s serious about science”

read at STAT ↗
474 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Dare Bioscience, Inc.
drugs
DisPATCH

related stories

  • 3d agoSTAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and moreSTAT
  • 3d agoOpinion: The most shocking thing about the latest statistics on CTE in football is that we find them so shockingSTAT
  • Aug 5STAT+: Why Schrödinger CEO Ramy Farid changed how he’s thinking about AISTAT
  • Jul 29STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicatedSTAT
  • Jul 22STAT+: What is a ‘world model’? Nabla’s Alex LeBrun explainsSTAT